Table 3.
United States Total Number of Qualifying Conditions (Total QCs), Total Qualifying Conditions That are Labeled With Conclusive/Substantial Evidence of Effectiveness (Number Effective), and Total Qualifying Conditions That are Labeled With Limited Evidence of Ineffectiveness (Number Ineffective) by the 2017 National Academies of Sciences, Engineering, and Medicine report11,a
| State | Total QCs 2017 | Number Effective 2017 (%) | Number Ineffective 2017 (%) | Total QCs 2024 | Number Effective 2024 (%) | Number Ineffective 2024 (%) |
|---|---|---|---|---|---|---|
| Alabama | N/A | - | - | 15 | 1 (6.7) | 0 (0) |
| Alaska | 8 | 1 (12.5) | 1 (12.5) | 8 | 1 (12.5) | 1 (12.5) |
| Arizona | 13 | 1 (7.7) | 2 (15.4) | 14 | 1 (7.1) | 2 (14.3) |
| Arkansas | 18 | 2 (11.1) | 2 (11.1) | 18 | 2 (11.1) | 2 (11.1) |
| California | 11 | 1 (9.1) | 1 (9.1) | 11 | 1 (9.1) | 1 (9.1) |
| Colorado | 8 | 1 (12.5) | 1 (12.5) | 11 | 1 (9.1) | 1 (9.1) |
| Connecticut | 21 | 0 (0) | 1 (4.8) | 40 | 6 (15.0) | 1 (2.5) |
| Delaware | 15 | 1 (6.7) | 1 (6.7) | 17 | 1 (5.9) | 2 (11.8) |
| District of Columbia | Provider discretion | - | - | Provider discretion | - | - |
| Florida | 13 | 1 (7.7) | 1 (7.7) | 13 | 1 (7.7) | 1 (7.7) |
| Hawaii | 15 | 1 (6.7) | 1 (6.7) | 15 | 1 (6.7) | 1 (6.7) |
| Illinois | 40 | 0 (0) | 2 (5.0) | 52 | 2 (3.9) | 2 (3.9) |
| Louisiana | 10 | 0 (0) | 0 (0) | 27 | 3 (11.1) | 3 (11.1) |
| Maine | 16 | 1 (6.3) | 2 (12.5) | Provider discretion | - | - |
| Maryland | 8 | 1 (12.5) | 1 (12.5) | 9 | 1 (11.1) | 1 (11.1) |
| Massachusetts | 8 | 0 (0) | 1 (12.5) | 8 | 0 (0) | 1 (12.5) |
| Michigan | 14 | 1 (7.1) | 2 (14.3) | 26 | 1 (3.9) | 2 (7.7) |
| Minnesota | 10 | 1 (10.0) | 1 (10.0) | 21 | 2 (9.5) | 2 (9.5) |
| Mississippi | N/A | - | - | 25 | 3 (12.0) | 3 (12) |
| Missouri | N/A | - | - | 24 | 2 (8.3) | 2 (8.3) |
| Montana | 15 | 2 (13.3) | 1 (6.7) | 15 | 2 (13.3) | 1 (6.7) |
| Nevada | 9 | 1 (11.1) | 1 (11.1) | 15 | 1 (6.7) | 1 (6.7) |
| New Hampshire | 18 | 0 (0) | 2 (11.1) | 24 | 2 (8.3) | 2 (8.3) |
| New Jersey | 14 | 0 (0) | 1 (7.1) | 17 | 1 (5.9) | 1 (5.9) |
| New Mexico | 21 | 2 (9.5) | 1 (4.8) | 22 | 2 (9.1) | 1 (4.5) |
| New York | 11 | 2 (18.2) | 0 (0) | Provider discretion | - | - |
| North Dakota | 18 | 1 (5.6) | 2 (11.1) | 29 | 2 (6.9) | 2 (6.9) |
| Ohio | 21 | 1 (4.8) | 2 (9.5) | 26 | 1 (3.9) | 2 (7.7) |
| Oklahoma | N/A | - | - | Provider discretion | - | - |
| Oregon | 10 | 1 (10.0) | 1 (10.0) | 10 | 1 (10.0) | 1 (10.0) |
| Pennsylvania | 17 | 2 (11.8) | 1 (5.9) | 24 | 2 (8.3) | 1 (4.2) |
| Rhode Island | 11 | 1 (9.1) | 2 (18.2) | 11 | 1 (9.1) | 1 (18.2) |
| South Dakota | N/A | - | - | 5 | 1 (20.0) | 0 (0) |
| Utah | N/A | - | - | 16 | 1 (6.3) | 1 (6.3) |
| Vermont | 12 | 1 (8.3) | 1 (8.3) | 12 | 1 (8.3) | 1 (8.3) |
| Virginia | N/A | - | - | Provider discretion | - | - |
| Washington | 21 | 1 (4.8) | 1 (4.8) | 21 | 1 (4.8) | 1 (4.8) |
| West Virginia | 15 | 2 (13.3) | 0 (0) | 15 | 2 (13.3) | 0 (0) |
a
Also included is the percent of the state’s total QCs in each category (%). States without QCs that permit provider discretion to recommend medical cannabis (MC) for any condition that they deem necessary are marked as provider discretion. States that had no MC in 2017 are marked as N/A.